Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma
|
The Pennsylvania State University / Ken Lucas, MD |
Innovation Grants |
2006 |
Pennsylvania |
Circulating Repetitive Element RNAs as an Osteosarcoma Marker |
Children’s Hospital Los Angeles / David Cobrinik, MD/PhD |
Innovation Grants |
2018 |
California |
Unraveling metabolic dependencies in childhood supratentorial ependymomas. |
Regents of the University of Michigan / Sriram Venneti, MD/PhD |
Innovation Grants |
2021 |
Michigan |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2012 |
California |
Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering |
Massachusetts General Hospital / Hanno Hock, M.D., Ph.D. |
Innovation Grants |
2014 |
Massachusetts |
Enhancing Pediatric Sarcoma Immunotherapy by Drug Induced Expression of Tumor-Specific Cryptic Neoantigens |
University of Minnesota / David Largaespada, PhD |
Innovation Grants |
2016 |
Minnesota |
Synergistic Differentiation Therapy in Neuroblastoma |
Duke University / Gerard Blobe, M.D./Ph.D |
Innovation Grants |
2015 |
North Carolina |
A leukemia organoid platform for dissection and targeting of tumor-niche interactions |
Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD |
Innovation Grants |
2021 |
New York |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |